Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05216016 · ClinicalTrials.gov registry record · NA
Minnesota RETAIN Phase 2 (Sub-study)
A NA study of Disability and Injuries Related Work, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 5,200
- Enrollment target
- 1
- Study location
NCT05216016 is a NA study of Disability and Injuries Related Work that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 5,200 participants, above the 477-participant average among 3 other Disability trials with a reported enrollment target (990% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05216016, a NA study of Disability and Injuries Related Work, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5,200 participants
- Enrollment target
- 1
- Study location
Study Summary
MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. (Effective Date: 12/23/2021-05/16/2024) MN RETAIN Phase 2 : This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. During this Phase: additional collaborators: Mathematica Policy Research
Conditions Studied
Interventions
- OTHER RETAIN Program
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,200 participants |
| Start Date | 2021-12-23 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05216016
The ClinicalTrials.gov registry entry for NCT05216016 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 477-participant average among 3 other Disability trials with a reported enrollment target (990% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Disability appearing as the primary indexed condition, and to 1 intervention - of which RETAIN Program is the first listed.
NCT05216016 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05216016 about?
NCT05216016 is a clinical study titled "Minnesota RETAIN Phase 2 (Sub-study)". MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Soc...
What is the current status of trial NCT05216016?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5,200 participants. The study started on 2021-12-23. Estimated completion is 2026-05.
What conditions does trial NCT05216016 study?
This clinical trial studies the following conditions: Disability, Injuries Related Work, Illness Related Work.
What interventions are being tested in trial NCT05216016?
The interventions under investigation include: RETAIN Program (OTHER).
Who is sponsoring clinical trial NCT05216016?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05216016 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.